🔎 Trials Near Me

Home › Type 1 Diabetes › New York

Type 1 Diabetes clinical trials in New York

23 studies for Type 1 Diabetes are looking for participants at sites in New York.

Cities in New York

App-Based Certified Diabetes Education Therapy (AB-CDE)

  • Mount Sinai School of Medicine, New York
Recruiting
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT07282639

A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes

  • University At Buffalo - Jacobs School Of Medicine- Site Number : 8400006, Buffalo
  • Endocrine Associates of West Village- Site Number : 8400064, New York
  • Columbia University Irving Medical Center- Site Number : 8400009, New York
RecruitingPhase 3
Ages 1 to 25 · All sexes · Updated Sep 14, 2026 · NCT07088068

CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)

  • UBMD Pediatrics - University of Buffalo, Buffalo
  • Hassenfield Children's Hospital, New York
  • NYU Langone Diabetes & Endocrine Associates, New York
RecruitingPhase 1/2
Ages 12 to 35 · All sexes · Updated Sep 11, 2026 · NCT06783309

Platform Trial to Delay Stage 3 Diabetes: Comparing Teplizumab With ATG

  • Columbia University, New York
RecruitingPhase 2
Ages 4 to 34 · All sexes · Updated Sep 9, 2026 · NCT07216391

Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus

  • Columbia University, New York
RecruitingPhase 2
Ages 8 to 45 · All sexes · Updated Sep 8, 2026 · NCT07142252

A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes

  • University of Buffalo, Buffalo
RecruitingPhase 1/2
Ages 9 to 20 · All sexes · Updated Sep 2, 2026 · NCT07061574

Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes

  • SUNY Upstate Medical Center, Albany
Recruiting
Ages 18 to 80 · All sexes · Updated Aug 28, 2026 · NCT07599982

HLA Demographics Study in Adults With Type 1 Diabetes

  • Icahn School of Medicine at Mount Sinai, New York
RecruitingObservational study
Ages 18 to 55 · All sexes · Updated Aug 28, 2026 · NCT06860516

Long-Term Outcomes of Teplizumab in Routine Clinical Care

  • Investigational Site Number: 8400001, New York
  • Investigational Site Number: 8400002, Syosset
RecruitingObservational study
All ages · All sexes · Updated Aug 25, 2026 · NCT07360080

SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes

  • University at Buffalo MD Physicians Group, Buffalo
RecruitingPhase 2
Ages 5 to 40 · All sexes · Updated Aug 24, 2026 · NCT07187531

APP-MNT: App-Enhanced Medical Nutrition Therapy on Glycemic Outcomes and Quality of Life

  • Weill Cornell Medicine, New York
Recruiting
Ages 18 to 75 · All sexes · Updated Aug 19, 2026 · NCT07773779

A Study of GNTI-122 in Adults Recently Diagnosed With T1D

  • Icahn School of Medicine at Mount Sinai, New York
  • Columbia University, New York
RecruitingPhase 1
Ages 18 to 55 · All sexes · Updated Aug 10, 2026 · NCT06919354

Post Market Registry for the Omnipod 5 System in Children and Adults With Type 1 Diabetes

  • Circuit Clinical, Buffalo
RecruitingObservational study
Ages 2 and older · All sexes · Updated Jul 1, 2026 · NCT06144554

Safety and Efficacy of Adjunct Therapies in Adults With Type 1 Diabetes: Multicenter, Registry Study

  • Mount Sinai, New York
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jun 30, 2026 · NCT07676565

Kidney Precision Medicine Project

  • Mount Sinai, New York
RecruitingObservational study
Ages 18 and older · All sexes · Updated Apr 14, 2026 · NCT04334707

Registry for Stage 2 Type 1 Diabetes

  • Women & Children's Hospital of Buffalo- Site Number : 8400018, Buffalo
  • Feinstein Institute for Medical Research (Northwell)- Site Number : 8400016, Manhasset
  • Ten's Medical PC- Site Number : 8400027, Staten Island
  • and 1 more
RecruitingObservational study
All ages · All sexes · Updated Apr 13, 2026 · NCT06481904

Hybrid Closed Loop Effectiveness Trial in Adults With Type 1 Diabetes

  • Montefiore Einstein Medical Center, The Bronx
Recruiting
Ages 18 to 75 · All sexes · Updated Apr 1, 2026 · NCT06236607

Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease

  • SUNY Upstate Medical University, Syracuse
  • Albert Einstein College of Medicine / Montefiore Medical Center, The Bronx
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Mar 24, 2026 · NCT06217302

Cholesterol Lowering and Residual Risk in Diabetes, Type 1

  • New York VA Hospital, New York
  • NYC Health + Hospitals/Bellevue, New York
  • NYU Langone Health, New York
  • and 1 more
RecruitingPhase 4
Ages 18 to 89 · All sexes · Updated Dec 29, 2025 · NCT05641753

Telemedicine-Delivered Unified Protocol for Cognitive Behavioral Therapy for Anxiety and Depression

  • Albert Einstein College of Medicine, The Bronx
Recruiting
Ages 18 to 64 · All sexes · Updated Oct 30, 2025 · NCT05734313

TrialNet Pathway to Prevention of T1D

  • Columbia University, New York
RecruitingObservational studyHealthy volunteers welcome
Ages 2 to 45 · All sexes · Updated Jul 1, 2025 · NCT00097292

NYSCF Scientific Discovery Biobank

  • New York Stem Cell Foundation Research Institute, New York
RecruitingObservational study
30 Days · All sexes · Updated Mar 3, 2025 · NCT06203106

PRenatal and Obstetric Maternal Exposures and ISlet Autoantibodies in Early Life

  • Mt Sinai, New York
RecruitingObservational studyHealthy volunteers welcome
0 Days – 99 Years · All sexes · Updated Nov 21, 2023 · NCT06141434

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.